17-alpha-Hydroxyprogesterone
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Hydroxyprogesterone caproate.
Acarbose
Acarbose may increase the hypoglycemic activities of Tolazamide.
Acebutolol
Acebutolol may increase the hypoglycemic activities of Tolazamide.
Advertisement
Acenocoumarol
Tolazamide may increase the anticoagulant activities of Acenocoumarol.
Acetohexamide
Acetohexamide may increase the hypoglycemic activities of Tolazamide.
Acetyl salicylate
Acetylsalicylic acid may increase the hypoglycemic activities of Tolazamide.
Advertisement
Albiglutide
Albiglutide may increase the hypoglycemic activities of Tolazamide.
Alogliptin
Alogliptin may increase the hypoglycemic activities of Tolazamide.
Aloxiprin
Aloxiprin may increase the hypoglycemic activities of Tolazamide.
Advertisement
Alprenolol
Alprenolol may increase the hypoglycemic activities of Tolazamide.
Aminosalicylic Acid
Aminosalicylic Acid may increase the hypoglycemic activities of Tolazamide.
Amiodarone
Amiodarone may increase the hypoglycemic activities of Tolazamide.
Amphetamine
Amphetamine may increase the hypoglycemic activities of Tolazamide.
Anhydrous Tacrolimus
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Tacrolimus.
Aripiprazole
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Aripiprazole.
Arsenic Trioxide
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Arsenic trioxide.
Articaine
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Articaine.
Asenapine
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Asenapine.
Aspirin
Acetylsalicylic acid may increase the hypoglycemic activities of Tolazamide.
Atazanavir
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Atazanavir.
Atenolol
Atenolol may increase the hypoglycemic activities of Tolazamide.
Atorvastatin
Atorvastatin may increase the hypoglycemic activities of Tolazamide.
Balsalazide
Balsalazide may increase the hypoglycemic activities of Tolazamide.
Bendroflumethiazide
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Bendroflumethiazide.
Benzthiazide
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Benzthiazide.
Betamethasone
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Betamethasone.
Betaxolol
Betaxolol may increase the hypoglycemic activities of Tolazamide.
Bezafibrate
Bezafibrate may increase the hypoglycemic activities of Tolazamide.
Bisoprolol
Bisoprolol may increase the hypoglycemic activities of Tolazamide.
Bopindolol
Bopindolol may increase the hypoglycemic activities of Tolazamide.
Brexpiprazole
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Brexpiprazole.
Bumetanide
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Bumetanide.
Bupranolol
Bupranolol may increase the hypoglycemic activities of Tolazamide.
Buserelin
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Buserelin.
Canagliflozin
Canagliflozin may increase the hypoglycemic activities of Tolazamide.
Canagliflozin Anhydrous
Canagliflozin may increase the hypoglycemic activities of Tolazamide.
Carbocysteine
The risk or severity of adverse effects can be increased when Tolazamide is combined with Carbocisteine.
Carteolol
Carteolol may increase the hypoglycemic activities of Tolazamide.
Carvedilol
Carvedilol may increase the hypoglycemic activities of Tolazamide.
Celiprolol
Celiprolol may increase the hypoglycemic activities of Tolazamide.
Ceritinib
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Ceritinib.
Chloramphenicol
The metabolism of Tolazamide can be decreased when combined with Chloramphenicol.
Chlorothiazide
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Chlorothiazide.
Chlorpropamide
Chlorpropamide may increase the hypoglycemic activities of Tolazamide.
Chlorthalidone
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Chlorthalidone.
Cimetidine
The serum concentration of Tolazamide can be increased when it is combined with Cimetidine.
Cinoxacin
Cinoxacin may increase the hypoglycemic activities of Tolazamide.
Ciprofibrate
Ciprofibrate may increase the hypoglycemic activities of Tolazamide.
Ciprofloxacin
Ciprofloxacin may increase the hypoglycemic activities of Tolazamide.
Citalopram
Citalopram may increase the hypoglycemic activities of Tolazamide.
Clofibrate
Clofibrate may increase the hypoglycemic activities of Tolazamide.
Clozapine
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Clozapine.
coenzyme Q10
The therapeutic efficacy of Tolazamide can be increased when used in combination with Ubidecarenone.
Corticotropin
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Corticotropin.
Cortisone Acetate
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Cortisone acetate.
Cyclopenthiazide
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Cyclopenthiazide.
Cyproterone Acetate
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Cyproterone acetate.
Dabrafenib
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Dabrafenib.
Danazol
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Danazol.
Dapagliflozin
Dapagliflozin may increase the hypoglycemic activities of Tolazamide.
Darunavir
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Darunavir.
Desipramine
Desipramine may increase the hypoglycemic activities of Tolazamide.
Desogestrel
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Desogestrel.
Desvenlafaxine
Desvenlafaxine may increase the hypoglycemic activities of Tolazamide.
Dexamethasone
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Dexamethasone.
Diazoxide
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Diazoxide.
Dicumarol
Tolazamide may increase the anticoagulant activities of Dicoumarol.
Dienogest
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Dienogest.
Diflunisal
Diflunisal may increase the hypoglycemic activities of Tolazamide.
Disopyramide
Disopyramide may increase the hypoglycemic activities of Tolazamide.
Drospirenone
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Drospirenone.
Dulaglutide
Dulaglutide may increase the hypoglycemic activities of Tolazamide.
Duloxetine
Duloxetine may increase the hypoglycemic activities of Tolazamide.
Empagliflozin
Empagliflozin may increase the hypoglycemic activities of Tolazamide.
Enoxacin
Enoxacin may increase the hypoglycemic activities of Tolazamide.
Epinephrine
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Epinephrine.
Ertugliflozin
Ertugliflozin may increase the hypoglycemic activities of Tolazamide.
Escitalopram
Escitalopram may increase the hypoglycemic activities of Tolazamide.
Esmolol
Esmolol may increase the hypoglycemic activities of Tolazamide.
Estradiol
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Estradiol.
Ethacrynate
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Etacrynic acid.
Ethacrynic Acid
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Etacrynic acid.
Ethanol
The risk or severity of adverse effects can be increased when Tolazamide is combined with Ethanol.
Ethinyl Estradiol
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Ethinyl Estradiol.
Ethynodiol Diacetate
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Ethynodiol diacetate.
Etofibrate
Etofibrate may increase the hypoglycemic activities of Tolazamide.
Etonogestrel
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Etonogestrel.
Everolimus
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Everolimus.
Exenatide
Exenatide may increase the hypoglycemic activities of Tolazamide.
Fenofibrate
Fenofibrate may increase the hypoglycemic activities of Tolazamide.
Fenofibric Acid
Fenofibric acid may increase the hypoglycemic activities of Tolazamide.
Fleroxacin
Fleroxacin may increase the hypoglycemic activities of Tolazamide.
Fluconazole
The serum concentration of Tolazamide can be increased when it is combined with Fluconazole.
Fludrocortisone
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Fludrocortisone.
Fluindione
Tolazamide may increase the anticoagulant activities of Fluindione.
Flumequine
Flumequine may increase the hypoglycemic activities of Tolazamide.
Fluoxetine
Fluoxetine may increase the hypoglycemic activities of Tolazamide.
Fluoxymesterone
Fluoxymesterone may increase the hypoglycemic activities of Tolazamide.
Fluvoxamine
Fluvoxamine may increase the hypoglycemic activities of Tolazamide.
Fosamprenavir
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Fosamprenavir.
Furazolidone
Furazolidone may increase the hypoglycemic activities of Tolazamide.
Furosemide
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Furosemide.
Gatifloxacin
Gatifloxacin may increase the hypoglycemic activities of Tolazamide.
Gatifloxacin Anhydrous
Gatifloxacin may increase the hypoglycemic activities of Tolazamide.
Gemfibrozil
Gemfibrozil may increase the hypoglycemic activities of Tolazamide.
Gemifloxacin
Gemifloxacin may increase the hypoglycemic activities of Tolazamide.
Gemifloxacin Mesylate
Gemifloxacin may increase the hypoglycemic activities of Tolazamide.
Glibornuride
Glibornuride may increase the hypoglycemic activities of Tolazamide.
Gliclazide
Tolazamide may increase the hypoglycemic activities of Gliclazide.
Glimepiride
Glimepiride may increase the hypoglycemic activities of Tolazamide.
Glipizide
Tolazamide may increase the hypoglycemic activities of Glipizide.
Gliquidone
Gliquidone may increase the hypoglycemic activities of Tolazamide.
Glyburide
Tolazamide may increase the hypoglycemic activities of Glyburide.
Goserelin
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Goserelin.
Grepafloxacin
Grepafloxacin may increase the hypoglycemic activities of Tolazamide.
Histrelin
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Histrelin.
Hydrochlorothiazide
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Hydrochlorothiazide.
Hydrocortisone
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Hydrocortisone.
Hydroflumethiazide
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Hydroflumethiazide.
hydroxyprogesterone caproate (USP)
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Hydroxyprogesterone caproate.
Iloperidone
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Iloperidone.
Indapamide
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Indapamide.
Indinavir
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Indinavir.
INDINAVIR ANHYDROUS
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Indinavir.
Insulin Detemir
Tolazamide may increase the hypoglycemic activities of Insulin Detemir.
Insulin Glargine
Insulin Glargine may increase the hypoglycemic activities of Tolazamide.
insulin human, rDNA origin
Insulin Human may increase the hypoglycemic activities of Tolazamide.
Insulin Lispro
Insulin Lispro may increase the hypoglycemic activities of Tolazamide.
Insulin, Aspart Protamine, Human
Tolazamide may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Aspart, Human
Tolazamide may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Glulisine, Human
Tolazamide may increase the hypoglycemic activities of Insulin Glulisine.
Insulin, Pork
Insulin Pork may increase the hypoglycemic activities of Tolazamide.
Insulin, Protamine Lispro, Human
Insulin Lispro may increase the hypoglycemic activities of Tolazamide.
Insulin, Regular, Pork
Insulin Pork may increase the hypoglycemic activities of Tolazamide.
Iproniazid
Iproniazid may increase the hypoglycemic activities of Tolazamide.
Isocarboxazid
Isocarboxazid may increase the hypoglycemic activities of Tolazamide.
Labetalol
Labetalol may increase the hypoglycemic activities of Tolazamide.
Lanreotide
Tolazamide may increase the hypoglycemic activities of Lanreotide.
Leuprolide
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Leuprolide.
Levobetaxolol
Levobetaxolol may increase the hypoglycemic activities of Tolazamide.
Levobunolol
Levobunolol may increase the hypoglycemic activities of Tolazamide.
Levofloxacin
Levofloxacin may increase the hypoglycemic activities of Tolazamide.
Levofloxacin Anhydrous
Levofloxacin may increase the hypoglycemic activities of Tolazamide.
Levomilnacipran
Levomilnacipran may increase the hypoglycemic activities of Tolazamide.
Levonorgestrel
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Levonorgestrel.
Linagliptin
Linagliptin may increase the hypoglycemic activities of Tolazamide.
Liraglutide
Liraglutide may increase the hypoglycemic activities of Tolazamide.
Lixisenatide
Lixisenatide may increase the hypoglycemic activities of Tolazamide.
Lomefloxacin
Lomefloxacin may increase the hypoglycemic activities of Tolazamide.
Lopinavir
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Lopinavir.
Lurasidone
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Lurasidone.
Mecasermin
Tolazamide may increase the hypoglycemic activities of Mecasermin.
Mecasermin Rinfabate
Tolazamide may increase the hypoglycemic activities of Mecasermin.
Medrogestone
The serum concentration of Tolazamide can be decreased when it is combined with Medrogestone.
Medroxyprogesterone Acetate
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Medroxyprogesterone acetate.
Megestrol Acetate
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Megestrol acetate.
Mepindolol
Mepindolol may increase the hypoglycemic activities of Tolazamide.
Mesalamine
Mesalazine may increase the hypoglycemic activities of Tolazamide.
Mesterolone
Mesterolone may increase the hypoglycemic activities of Tolazamide.
Mestranol
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Mestranol.
Metformin
Metformin may increase the hypoglycemic activities of Tolazamide.
Methotrimeprazine
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Methotrimeprazine.
Methyclothiazide
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Methyclothiazide.
Methyl Salicylate
Methyl salicylate may increase the hypoglycemic activities of Tolazamide.
Methylene blue
Methylene blue may increase the hypoglycemic activities of Tolazamide.
Methylprednisolone
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Methylprednisolone.
Methyltestosterone
Methyltestosterone may increase the hypoglycemic activities of Tolazamide.
Metipranolol
Metipranolol may increase the hypoglycemic activities of Tolazamide.
Metolazone
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Metolazone.
Metoprolol
Metoprolol may increase the hypoglycemic activities of Tolazamide.
Metreleptin
Metreleptin may increase the hypoglycemic activities of Tolazamide.
Miconazole
Miconazole may increase the hypoglycemic activities of Tolazamide.
Mifepristone
Mifepristone may increase the hypoglycemic activities of Tolazamide.
Miglitol
Miglitol may increase the hypoglycemic activities of Tolazamide.
Miglustat
Miglustat may increase the hypoglycemic activities of Tolazamide.
Milnacipran
Milnacipran may increase the hypoglycemic activities of Tolazamide.
Minaprine
Minaprine may increase the hypoglycemic activities of Tolazamide.
Moclobemide
Moclobemide may increase the hypoglycemic activities of Tolazamide.
Moxifloxacin
Moxifloxacin may increase the hypoglycemic activities of Tolazamide.
Nadolol
Nadolol may increase the hypoglycemic activities of Tolazamide.
Nalidixic Acid
Nalidixic Acid may increase the hypoglycemic activities of Tolazamide.
Nandrolone
Nandrolone may increase the hypoglycemic activities of Tolazamide.
Nandrolone Decanoate
Nandrolone decanoate may increase the hypoglycemic activities of Tolazamide.
Nateglinide
Nateglinide may increase the hypoglycemic activities of Tolazamide.
Nebivolol
Nebivolol may increase the hypoglycemic activities of Tolazamide.
Nefazodone
Nefazodone may increase the hypoglycemic activities of Tolazamide.
Nelfinavir
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Nelfinavir.
Niacin
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Niacin.
Nialamide
Nialamide may increase the hypoglycemic activities of Tolazamide.
Nilotinib
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Nilotinib.
Norethindrone
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Norethisterone.
Norfloxacin
Norfloxacin may increase the hypoglycemic activities of Tolazamide.
Norgestimate
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Norgestimate.
Octreotide
Octreotide may increase the hypoglycemic activities of Tolazamide.
Ofloxacin
Ofloxacin may increase the hypoglycemic activities of Tolazamide.
Olanzapine
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Olanzapine.
Olsalazine
Olsalazine may increase the hypoglycemic activities of Tolazamide.
Oxandrolone
Oxandrolone may increase the hypoglycemic activities of Tolazamide.
Oxprenolol
Oxprenolol may increase the hypoglycemic activities of Tolazamide.
Oxymetholone
Oxymetholone may increase the hypoglycemic activities of Tolazamide.
Paliperidone
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Paliperidone.
Pargyline
Pargyline may increase the hypoglycemic activities of Tolazamide.
Paroxetine
Paroxetine may increase the hypoglycemic activities of Tolazamide.
Pasireotide
Tolazamide may increase the hypoglycemic activities of Pasireotide.
Pefloxacin
Pefloxacin may increase the hypoglycemic activities of Tolazamide.
Pegvisomant
Pegvisomant may increase the hypoglycemic activities of Tolazamide.
Penbutolol
Penbutolol may increase the hypoglycemic activities of Tolazamide.
Pentamidine
Pentamidine may increase the hypoglycemic activities of Tolazamide.
Phenelzine
Phenelzine may increase the hypoglycemic activities of Tolazamide.
Phenformin
Phenformin may increase the hypoglycemic activities of Tolazamide.
Phenindione
Tolazamide may increase the anticoagulant activities of Phenindione.
Phenprocoumon
Tolazamide may increase the anticoagulant activities of Phenprocoumon.
Pindolol
Pindolol may increase the hypoglycemic activities of Tolazamide.
Pioglitazone
Pioglitazone may increase the hypoglycemic activities of Tolazamide.
Piperazine
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Piperazine.
Pipothiazine
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Pipotiazine.
Polythiazide
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Polythiazide.
Practolol
Practolol may increase the hypoglycemic activities of Tolazamide.
Pramlintide
Pramlintide may increase the hypoglycemic activities of Tolazamide.
Prednisolone
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Prednisolone.
Prednisone
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Prednisone.
Pregabalin
The risk or severity of heart failure can be increased when Pregabalin is combined with Tolazamide.
Probenecid
The protein binding of Tolazamide can be decreased when combined with Probenecid.
Procaine
Procaine may increase the hypoglycemic activities of Tolazamide.
Procarbazine
Procarbazine may increase the hypoglycemic activities of Tolazamide.
Progesterone
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Progesterone.
Propafenone
Propafenone may increase the hypoglycemic activities of Tolazamide.
Propranolol
Propranolol may increase the hypoglycemic activities of Tolazamide.
Quetiapine
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Quetiapine.
Quetiapine fumarate
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Quetiapine.
Quinethazone
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Quinethazone.
Quinine
Quinine may increase the hypoglycemic activities of Tolazamide.
Ranitidine
The serum concentration of Tolazamide can be increased when it is combined with Ranitidine.
Rasagiline
Rasagiline may increase the hypoglycemic activities of Tolazamide.
Regular Insulin, Human
Insulin Human may increase the hypoglycemic activities of Tolazamide.
Repaglinide
Tolazamide may increase the hypoglycemic activities of Repaglinide.
Rifampin
The serum concentration of Tolazamide can be decreased when it is combined with Rifampicin.
Risperidone
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Risperidone.
Ritonavir
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Ritonavir.
Rosiglitazone
Rosiglitazone may increase the hypoglycemic activities of Tolazamide.
Rosoxacin
Rosoxacin may increase the hypoglycemic activities of Tolazamide.
Salicylic Acid
Salicylic acid may increase the hypoglycemic activities of Tolazamide.
Saquinavir
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Saquinavir.
Saquinavir Mesylate
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Saquinavir.
Saxagliptin
Saxagliptin may increase the hypoglycemic activities of Tolazamide.
Saxagliptin Anhydrous
Saxagliptin may increase the hypoglycemic activities of Tolazamide.
Selegiline
Selegiline may increase the hypoglycemic activities of Tolazamide.
Semaglutide
Semaglutide may increase the hypoglycemic activities of Tolazamide.
Sertraline
Sertraline may increase the hypoglycemic activities of Tolazamide.
Sirolimus
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Sirolimus.
Sitagliptin
Sitagliptin may increase the hypoglycemic activities of Tolazamide.
Sitagliptin Phosphate
Sitagliptin may increase the hypoglycemic activities of Tolazamide.
Sotalol
Sotalol may increase the hypoglycemic activities of Tolazamide.
Sparfloxacin
Sparfloxacin may increase the hypoglycemic activities of Tolazamide.
Stanozolol
Stanozolol may increase the hypoglycemic activities of Tolazamide.
Sulfadiazine
Sulfadiazine may increase the hypoglycemic activities of Tolazamide.
Sulfamethoxazole
Tolazamide may increase the hypoglycemic activities of Sulfamethoxazole.
Sulfisoxazole
Sulfisoxazole may increase the hypoglycemic activities of Tolazamide.
Sunitinib
Tolazamide may increase the hypoglycemic activities of Sunitinib.
Tacrolimus
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Tacrolimus.
Talinolol
Talinolol may increase the hypoglycemic activities of Tolazamide.
Temafloxacin
Temafloxacin may increase the hypoglycemic activities of Tolazamide.
Temsirolimus
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Temsirolimus.
Terbutaline
Terbutaline may increase the hypoglycemic activities of Tolazamide.
Terbutaline Sulfate
Terbutaline may increase the hypoglycemic activities of Tolazamide.
Tertatolol
Tertatolol may increase the hypoglycemic activities of Tolazamide.
Testosterone
Testosterone may increase the hypoglycemic activities of Tolazamide.
Testosterone Cypionate
Testosterone cypionate may increase the hypoglycemic activities of Tolazamide.
Testosterone Enanthate
Testosterone enanthate may increase the hypoglycemic activities of Tolazamide.
Testosterone Propionate
Testosterone propionate may increase the hypoglycemic activities of Tolazamide.
Testosterone Undecanoate
Testosterone undecanoate may increase the hypoglycemic activities of Tolazamide.
Thioctic Acid
Lipoic Acid may increase the hypoglycemic activities of Tolazamide.
Timolol
Timolol may increase the hypoglycemic activities of Tolazamide.
Timolol Anhydrous
Timolol may increase the hypoglycemic activities of Tolazamide.
Tipranavir
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Tipranavir.
Tolbutamide
Tolazamide may increase the hypoglycemic activities of Tolbutamide.
Toloxatone
Toloxatone may increase the hypoglycemic activities of Tolazamide.
Torsemide
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Torasemide.
Tranylcypromine
Tranylcypromine may increase the hypoglycemic activities of Tolazamide.
Triamcinolone
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Triamcinolone.
Trichlormethiazide
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Trichlormethiazide.
Triptorelin
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Triptorelin.
Troglitazone
Troglitazone may increase the hypoglycemic activities of Tolazamide.
Trolamine Salicylate
Trolamine salicylate may increase the hypoglycemic activities of Tolazamide.
Trovafloxacin
Trovafloxacin may increase the hypoglycemic activities of Tolazamide.
Venlafaxine
Venlafaxine may increase the hypoglycemic activities of Tolazamide.
Vildagliptin
Vildagliptin may increase the hypoglycemic activities of Tolazamide.
Voriconazole
The serum concentration of Tolazamide can be increased when it is combined with Voriconazole.
Vorinostat
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Vorinostat.
Warfarin
Tolazamide may increase the anticoagulant activities of Warfarin.
Ziprasidone
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Ziprasidone.
